Abstract
Background
The magnitude of the association between diabetes (DM) and outcomes in elderly patients with acute coronary syndromes (ACS) is controversial. No study assessed the prognostic impact of DM according to frailty status in these patients.
Methods
The LONGEVO-SCA registry included unselected ACS patients aged ≥ 80 years. Frailty was assessed by the FRAIL scale. We evaluated the impact of previous known DM on the incidence of death or readmission at 6 months according to status frailty by the Cox regression method.
Results
A total of 532 patients were included. Mean age was 84.3 years, and 212 patients (39.8%) had previous DM diagnosis. Patients with DM had more comorbidities and higher prevalence of frailty (33% vs 21.9%, p = 0.002). The incidence of death or readmission at 6 months was higher in patients with DM (HR 1.52, 95% CI 1.12–2.05, p 0.007), but after adjusting for potential confounders this association was not significant. The association between DM and outcomes was not significant in robust patients, but it was especially significant in patients with frailty [HR 1.72 (1.05–2.81), p = 0.030, p value for interaction = 0.049].
Conclusions
About 40% of elderly patients with ACS had previous known DM diagnosis. The association between DM and outcomes was different according to frailty status.
Similar content being viewed by others
References
Guariguata L, Whiting DR, Hambleton I et al (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103:137–149. https://doi.org/10.1016/j.diabres.2013.11.002
Degano IR, Elosua R, Marrugat J (2013) Epidemiology of acute coronary syndromes in Spain: estimation of the number of cases and trends from 2005 to 2049. Rev Esp Cardiol 66:472–481. https://doi.org/10.1016/j.rec.2013.01.018
Krumholz HM, Gross CP, Peterson ED et al (2003) Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study. Am Heart J 146:839–847. https://doi.org/10.1016/S0002-8703(03)00408-3
Noman A, Balasubramaniam K, Alhous MHA et al (2017) Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus. Catheter Cardiovasc Interv 89:1195–1204. https://doi.org/10.1002/ccd.26882
De Servi S, Crimi G, Calabrò P et al (2016) Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. Eurointervention 12:312–318. https://doi.org/10.4244/EIJV12I3A51
Cordero A, López-Palop R, Carrillo P et al (2016) Comparison of long-term mortality for cardiac diseases in patients with versus without diabetes mellitus. Am J Cardiol 117:1088–1094. https://doi.org/10.1016/j.amjcard.2015.12.057
Klempfner R, Elis A, Matezky S et al (2015) Temporal trends in management and outcome of diabetic and non-diabetic patients with acute coronary syndrome (ACS): residual risk of long-term mortality persists: insights from the ACS Israeli Survey (ACSIS) 2000–2010. Int J Cardiol 179:546–551. https://doi.org/10.1016/j.ijcard.2014.10.116
Donahoe SM, Stewart GC, McCabe CH et al (2007) Diabetes and mortality following acute coronary syndromes. JAMA 298:765–775. https://doi.org/10.1001/jama.298.7.765
Savonitto S, Morici N, Cavallini C et al (2014) One-year mortality in elderly adults with non-ST-elevation acute coronary syndrome: effect of diabetic status and admission hyperglycemia. J Am Geriatr Soc 62:1297–1303. https://doi.org/10.1111/jgs.12900
Fu Z, Xue H, Guo J et al (2013) Long-term prognostic impact of cystatin C on acute coronary syndrome octogenarians with diabetes mellitus. Cardiovasc Diabetol 12:157. https://doi.org/10.1186/1475-2840-12-157
Morley JE (2008) Diabetes, sarcopenia, and frailty. Clin Geriatr Med 24:455–469. https://doi.org/10.1016/j.cger.2008.03.004
Sinclair AJ, Abdelhafiz AH, Rodríguez-Mañas L (2017) Frailty and sarcopenia - newly emerging and high impact complications of diabetes. J Diabetes Complicat 31:1465–1473. https://doi.org/10.1016/j.jdiacomp.2017.05.003
Ekerstad N, Swahn E, Janzon M et al (2011) Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation 124:2397–2404. https://doi.org/10.1161/CIRCULATIONAHA.111.025452
Núñez J, Ruiz V, Bonanad C et al (2017) Percutaneous coronary intervention and recurrent hospitalizations in elderly patients with non ST-segment acute coronary syndrome: The role of frailty. Int J Cardiol 228:456–458. https://doi.org/10.1016/j.ijcard.2016.11.151
Blanco S, Ferrières J, Bongard V et al (2017) Prognosis impact of frailty assessed by the Edmonton frail scale in the setting of acute coronary syndrome in the elderly. Can J Cardiol 33:933–939. https://doi.org/10.1016/j.cjca.2017.03.026
Sanchis J, Ruiz V, Bonanad C, Valero E et al (2017) Prognostic value of geriatric conditions beyond age after acute coronary syndrome. Mayo Clin Proc 92:934–939. https://doi.org/10.1016/j.mayocp.2017.01.018
Alonso Salinas GL, Sanmartin M et al (2017) Frailty is an independent prognostic marker in elderly patients with myocardial infarction. Clin Cardiol 40:925–931. https://doi.org/10.1002/clc.22749
Alegre O, Formiga F, López-Palop R et al (2018) An easy assessment of frailty at baseline independently predicts prognosis in very elderly patients with acute coronary syndromes. J Am Med Dir Assoc 19:296–303. https://doi.org/10.1016/j.jamda.2017.10.007
Li Y, Zou Y, Wang S et al (2015) A pilot study of the FRAIL scale on predicting outcomes in Chinese elderly people with type 2 diabetes. J Am Med Dir Assoc 16:714.e7–714.e714. https://doi.org/10.1016/j.jamda.2015.05.019
Alegre O, Ariza-Solé A, Vidán MT et al (2016) Impact of frailty and other geriatric syndromes on clinical management and outcomes in elderly patients with non-st-segment elevation acute coronary syndromes: rationale and design of the LONGEVO-SCA registry. Clin Cardiol 39:373–377. https://doi.org/10.1002/clc.22550
Fox KA, Dabbous OH, Goldberg RJ et al (2006) Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333:1091. https://doi.org/10.1136/bmj.38985.646481.55
Subherwal S, Bach RG, Chen AY et al (2009) Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) bleeding score. Circulation 119:1873–1882. https://doi.org/10.1161/CIRCULATIONAHA.108.828541
Abellan van Kan G, Rolland YM, Morley JE et al (2008) Frailty: toward a clinical definition. J Am Med Dir Assoc 9:71–72. https://doi.org/10.1016/j.jamda.2007.11.005
Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. A simple index of independence useful in scoring improvement in the rehabilitation of the chronically ill. Md State Med J 14:61–65
Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186
Pfeiffer E (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 23:433–441
Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Rubenstein LZ, Harker JO, Salvà A et al (2001) Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment. J Gerontol A Biol Sci Med Sci 56A:M366–M372
Hasin T, Hochadel M, Gitt AK et al (2009) Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus. Am J Cardiol 103:772–778. https://doi.org/10.1016/j.amjcard.2008.11.034
Franklin K, Goldberg RJ, Spencer F et al (2004) Implications of diabetes in patients with acute coronary syndromes. The global registry of acute coronary events. Arch Intern Med 164:1457–1463. https://doi.org/10.1001/archinte.164.13.1457
Sardu C, Paolisso P, Sacra C et al (2018) Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate. Cardiovasc Diabetol 17:137. https://doi.org/10.1186/s12933-018-0778-9
Sardu C, Marfella R, Santulli G (2014) Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people. J Cardiovasc Transl Res 7:362–368. https://doi.org/10.1007/s12265-014-9545-9
Marfella R, Sardu C, Balestrieri ML et al (2018) Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis. Diabetol Metab Syndr 10:1. https://doi.org/10.1186/s13098-017-0304-3
Sardu C, Barbieri M, Balestrieri ML et al (2018) Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up. Cardiovasc Diabetol 17:152. https://doi.org/10.1186/s12933-018-0795-8
Marfella R, Rizzo MR, Siniscalchi M et al (2013) Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage. Int J Cardiol 168:3954–3962. https://doi.org/10.1016/j.ijcard.2013.06.053
Vistisen D, Witte DR, Brunner EJ et al (2018) Risk of cardiovascular disease and death in individuals with prediabetes defined by different criteria: the Whitehall II Study. Diabetes Care 41:899–906. https://doi.org/10.2337/dc17-2530
Marfella R, Sardu C, Calabrò P et al (2018) Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: effects of incretin treatment. Diabetes Obes Metab 20:723–729. https://doi.org/10.1111/dom.13122
Balestrieri ML, Rizzo MR, Barbieri M et al (2015) Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment. Diabetes 64:1395–1406. https://doi.org/10.2337/db14-1149
Sardu C, Pieretti G, D’Onofrio N et al (2018) Inflammatory cytokines and SIRT1 levels in subcutaneous abdominal fat: relationship with cardiac performance in overweight pre-diabetics patients. Front Physiol 9:1030. https://doi.org/10.3389/fphys.2018.01030
Funding
The LONGEVO-SCA project has received a research grant from the Spanish Society of Cardiology (Proyectos de Investigaci?n Cl?nica SEC 2015).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Statement of human and animal rights
All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gual, M., Formiga, F., Ariza-Solé, A. et al. Diabetes mellitus, frailty and prognosis in very elderly patients with acute coronary syndromes. Aging Clin Exp Res 31, 1635–1643 (2019). https://doi.org/10.1007/s40520-018-01118-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-018-01118-x